214 related articles for article (PubMed ID: 18208364)
1. Targeting neutrophil elastase in cystic fibrosis.
Kelly E; Greene CM; McElvaney NG
Expert Opin Ther Targets; 2008 Feb; 12(2):145-57. PubMed ID: 18208364
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy.
Papayannopoulos V; Staab D; Zychlinsky A
PLoS One; 2011; 6(12):e28526. PubMed ID: 22174830
[TBL] [Abstract][Full Text] [Related]
3. Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis.
Kummarapurugu AB; Afosah DK; Sankaranarayanan NV; Navaz Gangji R; Zheng S; Kennedy T; Rubin BK; Voynow JA; Desai UR
J Biol Chem; 2018 Aug; 293(32):12480-12490. PubMed ID: 29903912
[TBL] [Abstract][Full Text] [Related]
4. Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis.
Barth P; Bruijnzeel P; Wach A; Sellier Kessler O; Hooftman L; Zimmermann J; Naue N; Huber B; Heimbeck I; Kappeler D; Timmer W; Chevalier E
J Cyst Fibros; 2020 Mar; 19(2):299-304. PubMed ID: 31501052
[TBL] [Abstract][Full Text] [Related]
5. Polysulfated Hyaluronan GlycoMira-1111 Inhibits Elastase and Improves Rheology in Cystic Fibrosis Sputum.
Kummarapurugu AB; Zheng S; Pulsipher A; Savage JR; Ma J; Rubin BK; Kennedy TP; Voynow JA
Am J Respir Cell Mol Biol; 2021 Feb; 64(2):260-267. PubMed ID: 33264072
[TBL] [Abstract][Full Text] [Related]
6. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease).
Roghanian A; Sallenave JM
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):125-44. PubMed ID: 18518838
[TBL] [Abstract][Full Text] [Related]
8. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
[TBL] [Abstract][Full Text] [Related]
9. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
[TBL] [Abstract][Full Text] [Related]
10. Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor.
Delacourt C; Hérigault S; Delclaux C; Poncin A; Levame M; Harf A; Saudubray F; Lafuma C
Am J Respir Cell Mol Biol; 2002 Mar; 26(3):290-7. PubMed ID: 11867337
[TBL] [Abstract][Full Text] [Related]
11. Profile of the ProAxsis active neutrophil elastase immunoassay for precision medicine in chronic respiratory disease.
Keir HR; Fong CJ; Dicker AJ; Chalmers JD
Expert Rev Mol Diagn; 2017 Oct; 17(10):875-884. PubMed ID: 28854829
[TBL] [Abstract][Full Text] [Related]
12. Opportunities for the use of aerosolized alpha 1-antitrypsin for the treatment of cystic fibrosis.
Allen ED
Chest; 1996 Dec; 110(6 Suppl):256S-260S. PubMed ID: 8989161
[TBL] [Abstract][Full Text] [Related]
13. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
[TBL] [Abstract][Full Text] [Related]
14. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions.
Rees DD; Rogers RA; Cooley J; Mandle RJ; Kenney DM; Remold-O'Donnell E
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):69-78. PubMed ID: 9870919
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil elastase inhibitors: a patent review and potential applications for inflammatory lung diseases (2010 - 2014).
Tsai YF; Hwang TL
Expert Opin Ther Pat; 2015; 25(10):1145-58. PubMed ID: 26118988
[TBL] [Abstract][Full Text] [Related]
17. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.
Gehrig S; Duerr J; Weitnauer M; Wagner CJ; Graeber SY; Schatterny J; Hirtz S; Belaaouaj A; Dalpke AH; Schultz C; Mall MA
Am J Respir Crit Care Med; 2014 May; 189(9):1082-92. PubMed ID: 24678594
[TBL] [Abstract][Full Text] [Related]
18. Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8.
Taggart C; Coakley RJ; Greally P; Canny G; O'Neill SJ; McElvaney NG
Am J Physiol Lung Cell Mol Physiol; 2000 Jan; 278(1):L33-41. PubMed ID: 10645888
[TBL] [Abstract][Full Text] [Related]
19. The role of neutrophils in cystic fibrosis.
Gifford AM; Chalmers JD
Curr Opin Hematol; 2014 Jan; 21(1):16-22. PubMed ID: 24253427
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neutrophil elastase in CF sputum by L-658,758.
Rees DD; Brain JD; Wohl ME; Humes JL; Mumford RA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1201-6. PubMed ID: 9399994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
